The life sciences industry is a rapidly growing market around the world and appears to have special importance in Lithuania. TGS Baltic Partner Dalia Tamasauskaite-Ziliene and Glimstedt Partner Ausra Maliauskaite-Embrekte explore the key developments in the field and the main drivers behind them.
Voicu & Filipescu Successful in Medical Malpractice Case Before Romanian Courts
Voicu & Filipescu has successfully represented a client before the court of first instance and on appeal in a medical malpractice case, being awarded RON 550,000 in damages.
Wardynski & Partners Advises Genomtec on WSE Main Market Listing
Wardynski & Partners has advised Genomtec on the transfer of its listing from NewConnect to the main market of the Warsaw Stock Exchange.
B2RLaw Advises Moffitt Cancer Center and OncoBay Clinical on Clinscience PLN 150 Million Investment in OncoBay
B2RLaw has advised the Moffitt Cancer Center and its for-profit subsidiary OncoBay Clinical on Clinscience's USD 33.5 million investment in OncoBay.
Taylor Wessing and KPMG Law Advise on Amedes Group Acquisition of ArchimedLife
Taylor Wessing has advised the Amedes Group on its acquisition of the remaining 49% stake in ArchimedLife from VLSI Holding. KPMG Law advised the seller.
TGS Baltic Advises Nordic Foodtech VC on Investment in Aio Tech
TGS Baltic has advised Nordic Foodtech VC on its investment in Tallinn-based biotechnology R&D start-up Aio Tech.
Compilation of Key Legal Developments About Health and Life Science
The new act on the limitation of the environmental impact of selected plastic products (the “Act”) is a transposition of the European Directives 2008/98/EC on waste and in particular the 2019/904 on the reduction of the impact of certain plastic products on the environment.